Shiga Toxin
Medical Supply
Meridian Bioscience Inc.
Total Payments
$77,816
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $55,283 | 2 | 0 |
| 2020 | $22,533 | 7 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $55,283 | 2 | 71.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,533 | 7 | 29.0% |
Payments by Type
Research
$55,283
2 transactions
General
$22,533
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Curian Shiga Toxin Clinial Trial | Meridian Bioscience Inc. | $55,283 | 0 |
Top Doctors Receiving Payments for Shiga Toxin
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $77,816 | 9 |
Ad
Manufacturing Companies
- Meridian Bioscience Inc. $77,816
Product Information
- Type Medical Supply
- Total Payments $77,816
- Total Doctors 0
- Transactions 9
About Shiga Toxin
Shiga Toxin is a medical supply associated with $77,816 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Meridian Bioscience Inc..
Payment data is available from 2020 to 2022. In 2022, $55,283 was paid across 2 transactions to 0 doctors.
The most common payment nature for Shiga Toxin is "Unspecified" ($55,283, 71.0% of total).
Shiga Toxin is associated with 1 research study, including "Curian Shiga Toxin Clinial Trial" ($55,283).